Introduction
Cocaine, one of the most commonly abused psychostimulants induces the elevation of extracellular dopamine in the striatum by blocking the dopamine transporter (DAT). The dopaminergic system including D 1 , D 2 dopamine receptors and DAT has been shown to play a key role in mediating the locomotor, rewarding, reinforcing, sensitising and stereotypic effects of cocaine (for review see Anderson & Pierce (2005) ).
In addition, neurochemical data also supports the presence of interactions between cocaine and the dopaminergic system. There are multiple studies investigating the effect of cocaine on D 1 and D 2 receptor and DAT density with inconsistent findings with each other. Increases, decreases or no change in D 1 receptor binding, D 2 receptor binding (Taylor et al., 1979; Goeders & Kuhar, 1987; Peris et al., 1990; Volkow et al., 1990; Volkow et al., 1993; Berrettini et al., 1994; Unterwald et al., 1994; Maggos et al., 1998; Nader & Czoty, 2005; Nader et al., 2006; Bailey et al., 2007b) and DAT binding (Kula & Baldessarini, 1991; Sharpe et al., 1991; Benmansour et al., 1992; Farfel et al., 1992; Alburges et al., 1993; Cass et al., 1993; Hurd & Herkenham, 1993; Little et al., 1993; Pilotte et al., 1994; Staley et al., 1994; Wilson et al., 1994a; Wilson et al., 1994b; Hitri et al., 1996; Pilotte et al., 1996; Kunko et al., 1997; Maggos et al., 1997; Little et al., 1998a; Little et al., 1999; Bailey et al., 2007b) have been reported. The lack of concordance in the above studies may arise from differences in treatment paradigms (varying doses, schedule and route of administration), length of withdrawal of receptor measurement in relation to the last cocaine injection and/or ligands used to quantify receptors and DAT. Nonetheless, a decrease in D 2 availability as measured with positron emission tomography (PET) in cocaine abstinent humans, non human primates and rats has been repeatedly and consistently observed (Volkow et al., 1990; Volkow et al., 1993; Tsukada et al., 1996; Maggos et al., 1998; Nader & Czoty, 2005; Nader et al., 2006) and is thought to be associated with vulnerability to the reinforcing effects of drugs of abuse.
The aim of our study is to characterise the behavioural and neurochemical effect of cocaine on the dopaminergic system of mice treated with an escalating dose "binge" cocaine administration paradigm which closely mimics common features of human cocaine abuse and to compare that with those of traditionally used chronic steady dose "binge" cocaine administration paradigm. A common feature of human cocaine abuse is the development, over time, of tolerance to the reinforcing effects of cocaine, which results in administration of increasing doses of cocaine (Koob & Kreek, 2007) . Indeed, novel animal models of excessive drug taking in dependent animals have recently been developed which demonstrate that rats which are trained to self administer cocaine over a long time, display a number of behavioural patterns consistent with those commonly observed in human cocaine addicts, including a progressive escalation in drug consumption, elevated drug-directed behaviours during extinction/abstinence and increased susceptibility to cocaine induced relapse which are thought to be related to the transition to cocaine addiction . Recent studies have also shown dramatic dysregulation of brain reward pathways (Ahmed & Koob, 1998; Ahmed et al., 2003; Ahmed & Koob, 2004) , activation of brain stress systems in the extended amygdala (Zorrilla et al., 2001; Mantsch et al., 2003) and profound changes in the μ-(MOP-r) and κ-(KOP-r) opioid receptors systems Schlussman et al., 2005; Bailey et al., 2007a ) in animal models of escalating "binge" cocaine administration. This study was designed in order to investigate the effects of this novel chronic escalating dose cocaine administration paradigm on locomotion and stereotypy and on the levels of DAT, D 1 , D 2 receptor binding and D 2 stimulated G-protein activity in different brain regions of C57BL/6J mice brains and to compare it with traditionally used steady dose administration paradigms.
The results would give us an insight of possible behavioural and neurochemical changes taking place in the dopaminergic system which might underlie the transition from drug use to compulsive drug use associated with addiction, which is a process of escalation. In addition, this is the first study which investigated the effect of chronic cocaine use on D 2 receptor G protein activity with the use of quinerolane stimulated [
35 S]GTPγS autoradiography. These results, which may indeed differ from those obtained with D 2 receptor binding, may provide important information on the biochemical basis of the behavioural sensitisation properties of cocaine.
Materials and Methods
Animals and chronic cocaine treatment 6-8 week old C57BL/6J mice, 20-25 g, were studied. Mice were housed individually in a temperature-controlled room, with a 12 h light/dark schedule. Food and water were available ad libitum. All animals were weighed daily throughout the study. After 7 days of acclimatisation, intraperitoneal (i.p.) injections of either saline (1ml/kg) or cocaine were then administered in an escalating or steady dose ''binge'' paradigm to mimic a common pattern of self-administration in human cocaine abusers (Tsukada et al, 1996) . Animals in the escalating dose group received 15x3 mg/kg/day on days 1-4, 20x3 mg/kg/day on days 5-8, 25x3 mg/kg/day on days 9-12, and 30x3 mg/kg/day on days 13 and 14. For animals treated with a chronic steady dose "binge" administration paradigm, 15 x 3 mg/kg/day were administered for 14 days. Three i.p. injections (1 h apart) were administered daily, with the first injection 60 min after the start of the light cycle. Animals were randomized into four groups of 6-12. Each group received either saline or cocaine injections for 14 days. Thirty minutes after the last injection, animals were killed by decapitation after a 15 second exposure to CO 2 . Brains were rapidly removed and frozen by immersion for 30 seconds in isopentane cooled to -35°C. All studies were performed in accordance with protocols approved by the Home Office (Animals Act 1986) UK.
Cocaine-induced locomotor activity
Locomotor activity was measured by the use of 12 motility chambers (40cm length x 20 cm wide x 20 cm height) (Linton Instrumentation, Norfolk, UK). Each cage had two sets of 16 photocells located at right angles to each other, projecting horizontal infrared beams 2.5 cm apart and 1 and 6 cm above the cage floor. The protocol for locomotor testing was a slight modification of that used by Heidbreder et al. (1998) . When mice were tested in the activity chambers, they were habituated for 60 min after which they received an i.p. injection of saline or cocaine. The animals were then returned immediately to the chambers where locomotor activity was assessed for 60 min. The mice received a second and third injection of saline or cocaine 60 min and 120 min respectively after the first one and then returned immediately to the chambers where locomotor activity was assessed for 60 min. The locomotor activity for each mouse after each of the three daily injections of saline or cocaine was monitored daily for a period of 14 days. Locomotor activity was defined as the activity from measurement of sequential infrared beam breaks, recorded every 5 min, beginning immediately after placing the animals in the cage following an injection of saline or cocaine and continued for a 60 min period. For measurement of basal activity, mice were habituated for 60 min in the motility boxes prior to injections. Another group of mice were treated with 1 day acute "binge" cocaine administration protocol in order to compare the locomotor activity of mice at the end of the chronic escalating dose "binge" cocaine administration protocol with those treated acutely for 1 day with "binge" cocaine. Mice received three i.p. injections (1 h apart) of cocaine (30 x 3 mg/kg/day) for only 1 day and locomotor activity was measured for 60 min after each injection.
Cocaine-induced stereotypy
All mice receiving either saline or cocaine were videotaped twenty minutes after each injection for 30 sec. Videotapes were later rated for stereotypy by a trained observer blind as to the animal's treatment group. The rating was based on a slight adaptation of the scale used by Schlussman et al., (2003) Quantitative autoradiography was performed as detailed previously for D 1 , D 2 dopamine receptor binding (Lena et al., 2004) and DAT binding (Javitch et al., 1985) using the general procedures of Kitchen et al. (1997) . Adjacent 20 μm coronal sections were cut at a interval of 300 μm from chronic "binge" saline or cocaine treated mice brains for the determination of total and non-specific binding of weeks. Sections from chronic "binge" saline and cocaine treated mice were processed together in a paired protocol. Films were developed using 50% Kodak D19 developer.
Quantitative analysis of brain receptors was performed as detailed previously (Kitchen et al., 1997; Lena et al., 2004) . Using an MCID image analyser (Image Research, Canada), brain structures were identified using the mouse brain atlas of Franklin and Paxinos (1997) . The following structures were analysed by sampling 5-10 times with a box tool: cortex (8 x 8 mm)
and olfactory tubercle (6 x 6 mm). All the other areas were analysed using freehand drawing Sections were then incubated in assay buffer containing 2 mM GDP, pH 7.4 at 25 °C for 15 min. D 2 receptor agonist stimulated activity was determined by incubating the sections in (100μM) and raclopride (10 μM) in assay buffer containing 2 mM GDP. After incubation for 2 h, slides were rinsed twice for 3 min in icecold buffer (50 mM Tris/HCl, pH 7.4 at 0°C) followed by one rinse in de-ionised water.
Slides were then dried for 2 h in a cold air stream and drying was continued for a further 2 days using anhydrous calcium sulfate (Drierite, BDHChemicals, Poole, UK). Sections from the brains of chronic cocaine treated mice and chronic saline treated mice were apposed to (1250 Ci/mmol) were purchased from Perkin Elmer (Bucks, UK); cis flupenthixol, sulpiride, raclopride, quinerolane, GDP, GTPγS and mazindol were purchased from Sigma-Aldrich.
Results
Locomotor activity during chronic escalating and steady dose "binge" cocaine administration
Locomotor activity of naïve C57BL/6J mice (before saline or cocaine treatment) was measured for 60 min after placement in the locomotor chambers. The last 5 min of the 60 min duration on day 1 is shown in Fig. 1 . One-way ANOVA, did not show any significant effect on basal locomotor activity between the two groups on day 1 (P>0.05). Basal locomotor activity between the two treatment groups were measured during the 14 days of the study.
Greater basal locomotor activity was observed in the cocaine treated group compared to saline on days 2-14 (P<0.01) (Fig. 1 ).
Locomotor activity of C57BL/6J mice was measured after each of the three hourly daily injections of saline or cocaine (15-30 x 3 mg/kg/day) from day 1 to day 14 of the chronic escalating dose "binge" cocaine treatment (Fig. 1a) . Two-way ANOVA showed a significant main effect treatment (P<0.0001) and day (P<0.0001) and treatment x day interaction (P<0.0001). Mice treated with cocaine had greater locomotor activity compared to saline on all treatment days (P<0.0001, Newman-Keuls post hoc test) (Fig.1a) . A significant increase in cocaine-induced locomotor activity was observed on day 3 (15 x 3 mg/kg/day) compared to day 1 (15 x 3 mg/kg/day) (P<0.0001) indicating the presence of behavioural sensitisation to the locomotor-stimulating effect of cocaine. Moreover an increase in cocaine-induced locomotor activity was observed on day 5 (20 x 3 mg/kg/day) vs day 1 (P<0.0001), day 9 (25 x 3 mg/kg/day) vs day 5 (P<0.01), and day 13 (30 x 3 mg/kg/day) vs day 9 (P<0.01)
indicating that the increase in cocaine-induced locomotion is dose dependent. Both the magnitude and the duration of the cocaine response was enhanced on day 3 compared to day 1. However, although the magnitude of the cocaine response did not increase, a dramatic increase in the duration of cocaine-induced hyperactivity was observed following the increase of the cocaine dose from 20 to 25 mg/kg/inj and from 25 to 30 mg/kg/inj (Fig. 1a) . On day 5, activity of the cocaine-injected animals returned to baseline levels 60 min after each of the three cocaine injections. However, on day 13 the activity of cocaine-injected animals remained constantly elevated at its peak magnitude during the whole 60 min after each of the three cocaine injections (Fig.1a) .
Another group of mice were injected with 30 x 3 mg/kg/day cocaine at 1 h intervals for only 1 day to compare locomotor activity of mice on day 13 (30 x 3 mg/kg/day) of the escalating dose "binge" cocaine administration and after acute (1 day) "binge" cocaine administration (30 x 3 mg/kg/day). In contrast with the chronic paradigm where the duration of the peak cocaine response persisted for at least 60 min after cocaine administration, the activity of 1 day acute cocaine treated animals (3x30 mg/kg) returned to baseline 60 min after each of the three cocaine injections (Fig. 1a) .
Other groups of mice were treated with a steady dose (3x15 mg/kg/day) cocaine administration protocol for 14 days (Fig. 1b) . Cocaine increased locomotor activity compared to saline every day during the 14 day duration of the study (P<0.001, Newman-Keuls post hoc test). A significant increase in cocaine induced locomotor activity was observed on day 3 compared to day 1 (P<0.001) which persisted up to day 5 indicating the presence of behavioural sensitisation to the locomotor effect of cocaine (Fig. 1b) . A reduction in cocaineinduced locomotor activity was observed on day 9 and day 13 vs day 5 of our chronic steady dose paradigm (Fig. 1b) . In contrast to the escalating dose paradigm, the activity of cocaine injected animals returned to baseline levels 60 min after each of the three cocaine injections every day during the 14 day duration of the study (Fig. 1b) .
Stereotypy behaviour during chronic escalating and steady dose "binge" cocaine administration Stereotypy activity of C57BL/6J mice was scored 20 min after each of the three injections of saline or cocaine every day for the whole duration of the study and the median score of the three daily injections have recorded (Fig. 2) . For the escalating dose group, two-way ANOVA showed a significant main effect of treatment (P<0.0001), day (P<0.0001) and significant treatment x day interaction (P<0.0001). Newman-Keuls post hoc test showed that escalating dose "binge" pattern cocaine administration resulted in a significant expression of behavioural stereotypy (P<0.0001) compared to saline controls (Fig. 2a) . A significant increase in cocaine-induced stereotypy was observed on day 3 (15 x 3 mg/kg/day) compared to day 1 (15 x 3 mg/kg/day) (P<0.0001) indicating the presence of behavioural sensitisation to the stereotypy-stimulating effect of cocaine. Moreover an increase in cocaine-induced stereotypy behaviour was observed on day 5 (20 x 3 mg/kg/day) vs day 1 (P<0.0001), day 9
(25 mg/kg/day) vs day 5 (P<0.05), but not on day 13 (3 x 30 mg/kg/day) vs day 9 (P>0.05).
As far as the steady dose group is concerned, cocaine increased stereotypy behaviour every day during the 14 day duration of the chronic steady dose (3 x 15 mg/kg/day) cocaine administration study compared to saline control (P<0.001) (Fig. 2b) . A significant increase in cocaine-induced stereotypy was observed on day 3 compared to day 1 which persisted for the rest of the duration of the study indicating the presence of behavioural sensitisation to the stereotypy stimulatory effect of cocaine (Fig. 2b) . In contrast to the escalating dose paradigm, no increase in cocaine-induced stereotypy behaviour was observed on day 9 vs day 5 (P>0.05) (Fig. 2b) . (Figs. 3, 4A ). For DAT binding, two way ANOVA also showed a significant main effect of treatment (P < 0.001). In contrast to D 2 binding, significantly higher levels of DAT binding were observed in the nucleus accumbens shell (P<0.01) and core (P<0.01), in the olfactory tubercle (P<0.01) and in all regions the caudate putamen (P<0.05) of chronic cocaine-treated mice compared to saline controls (Figs. 3, 4B ). There was no significant treatment effect on D 1 binding (Fig. 3, 4C ) (P>0.05).
Quinelorane-stimulated [ cocaine-treated animals compared to saline controls (Fig. 6a) 
Discussion
The behavioural results obtained in this study indicate the initial presence of locomotor sensitization to the locomotor effect of cocaine, followed by a dose dependent increase in the duration but not the magnitude of the locomotor activating effect of cocaine. In our locomotor paradigm of chronic "binge" cocaine administration, behavioural sensitisation could be reflected by the increase in the magnitude (maximum or peak response) as measured by increased amount of counts at the time point where the counts are maximal (peak counts)
or by increased duration of the locomotor effect of cocaine. Indeed in our escalating dose paradigm (see Fig. 1a ) an increase in the peak locomotor effect of cocaine in day 3 compared to day 1 and an increase in the duration of the cocaine effect on day 13 (without observing an increase in the peak response to cocaine) compared to day 3 were observed, which is an indication of behavioural sensitisation. However, in our steady dose paradigm, an increase in the peak locomotor effect of cocaine was observed in day 3 compared to day 1 (initial sensitisation), but a decrease in the peak locomotor effect of cocaine was observed in day 13 compared to day 3 without alteration of the duration of the locomotor effect of cocaine, which indicates a lack of sensitisation effect at that time point. These results suggest an increase of behavioural sensitisation on day 13 of our escalating dose cocaine administration paradigm but not in our steady dose paradigm. These results are in agreement with Foltin et al., (2003) who compared the effects of escalating doses of smoked cocaine with a fixed dosing group in humans. They demonstrated a dose-dependent increase in heart rate, blood pressure, ratings of positive drug effect in the escalating dose group and a maintenance of the initial cocaine effect throughout the whole study in the fixed group. Together these results demonstrate that increasing the dose of cocaine during a "binge" of cocaine use can increase the effect of cocaine, but administering the same cocaine dose maintains, but not increases the effect of cocaine suggesting the presence of different neurobiological mechanisms that underlie the transition from drug use to compulsive drug use associated with addiction, which is a process of escalation.
The initial sensitization effect of cocaine observed in our study is in agreement with the development of locomotor sensitization observed in C57BL/6J mice in our study and in others using a 14 day steady dose "binge" pattern (15 x 3 mg/kg/day) cocaine administration paradigm (Unterwald et al., 1994; Bailey et al., 2007a) , but in contrast with Schlussman et al., (2003) who showed tolerance to the locomotor effect of cocaine in C57BL/6J mice treated the same chronic steady dose "binge" paradigm as above, in their home cage. This discrepancy is likely to be due to the different environment where the drug was administered during the chronic "binge" paradigm (home cage vs novel environment). Indeed, it has been reported that sensitisation is more robust when cocaine is repeatedly administered outside the home cage than in the home cage (Badiani et al., 1995; Browman et al., 1998; Uslaner et al., 2003) .
As a result, the increase in the duration of cocaine action observed in days 9-14 of our escalating dose paradigm is unlikely to be due to a dose effect rather than sensitization as we did not observe any increase in the duration of the cocaine effect when mice were treated with an acute 3 x 30 mg/kg (Fig 1a) or during any day of the 14 day steady dose cocaine (3 x 15 mg/kg/day) administration paradigm. This is in agreement with Daunais and McGinty (1995) who found no differences in the behavioural rating scores of male Wistar rats which received 30 or 60 mg/kg of cocaine in daily "binges", suggesting that the expression of behavioural activity has reached a maximum at the relatively high dose of 15 mg/kg/injection. As a result, other factors such as the dysregulation of the dopaminergic system may account for the locomotor effects of chronic "binge" escalating dose cocaine administration.
In accordance with the locomotor activity data, behavioural sensitization to the stereotypy inducing effect of cocaine, followed by an increase in magnitude of stereotypy score on day 9 compared to day 5, but not on day 13 vs day 9 where the stereotypy effect of cocaine seems to reach saturation, was observed in our escalating dose study. An initial sensitisation was observed on day 3 of our steady dose paradigm which persisted throughout the rest of the duration of the study. These findings are in contrast with studies showing a lack of sensitisation to the stereotypy behaviour during an identical 14 day "binge" escalating dose cocaine administration paradigm in rats (Schlussman et al., 2005) and during a 14 day steady dose (15 x 3 mg/kg/day) "binge" cocaine administration in rats (Schlussman et al., 2005) and C57BL/6J mice (Schlussman et al., 2003; Bailey et al., 2007a) . This divergence is again likely to be due to the different environment where the drug was administered during the chronic "binge" paradigm reinforcing the importance of home cage vs novel environment.
As discussed above, there is a profound difference in the behavioural effect of cocaine when administered in a chronic "binge" escalating dose (15-30 x 3 mg/kg/day) paradigm compared to a chronic "binge" steady dose (15 x 3 mg/kg/day) paradigm. We hypothesised that these changes might be due to profound alterations in the dopamine neurotransmission during escalation of cocaine administration which may not take place during steady dose administration. In support of this, Ahmed et al., (2003) showed that rats which escalate their intake of cocaine maintain greater levels of dopamine in the nucleus accumbens and are more sensitive to the actions of the selective dopamine antagonist cis-flupenthixol than rats which had limited access to the drug (steady dose) and that this phenomenon is not associated with a change in cocaine pharmacokinetics or efficacy. The above findings support the hypothesis that a decrease in dopamine neurotransmission contributes to escalation of cocaine self administration.
Although there have been numerous studies investigating the effect of chronic cocaine administration on D 1 , D 2 dopamine receptor and DAT with conflicting results (see introduction), this is the first study which has investigated the effects of cocaine administered in a chronic "binge" escalating dose pattern which more closely mimics human drug abuse, on D 1 , D 2 dopamine receptor, DAT binding and D 2 stimulated G protein activity. A significant decrease in D 2 receptor density was observed in all regions of the striatum of cocaine-treated mice compared to saline controls. This is in agreement with the consistent finding of a decrease in D 2 receptor availability and binding as measured by PET and in vitro autoradiography in the brains of cocaine abstinent humans, non human primates and rats (Volkow et al., 1990; Volkow et al., 1993; Moore et al., 1998; Nader et al., 2002; Nader & Czoty, 2005; Nader et al., 2006) and could reflect receptor downregulation from the exposure to a higher extracellular dopamine concentration due to chronic blockade of dopamine transporters. Moreover, and in accordance with Ahmed et al., (2004) , this decrease in D 2 receptors may be indicative of a "hypodopaminergic" system which is in need of escalating doses of cocaine to maintain increased levels of dopamine in the nucleus accumbens.
Interestingly, our results are in contrast with those from our group (Bailey et al., 2007b) and others (Unterwald et al., 1994) who showed a lack of decrease in D 2 receptor binding when using a 14 day steady dose "binge" cocaine (15 x 3 mg/kg/day) administration paradigm, suggesting that cocaine-induced changes in D 2 receptors is dependent on the paradigm used (steady vs escalating). This is in agreement with Nader and Czoty, (2005) receptor sensitivity observed in these mice. This is the first study which provides biochemical evidence for the increase of sensitivity of D 2 receptors following chronic escalating dose "binge" cocaine treatment despite the decrease of D 2 receptor density.
The increase in D 2 receptor coupling to G protein in our study is unlikely to be due to increase in pertussis toxin sensitive G protein (G i/o ) which couples to D 2 receptors as it has been shown that cocaine decreases G i/o in the nucleus accumbens of rats (Nestler et al., 1990) . Alterations of other factors downstream of the receptor affecting G i/o coupling to D 2 receptors in response to chronic cocaine administration might play an important role. For instance alterations in Gprotein coupled receptor kinase 6 (GRK6), which is known to be involved in D 2 receptor desensitisation, might be a possible candidate, as enhanced G protein coupling to D 2 receptors and augmented locomotor responses to cocaine was observed in mice deficient in GRK6 (Gainetdinov et al., 2003) . The mechanism involved in the increase in D 2 receptor coupling in escalating dose cocaine treated mice is not clear. It could be the result of a homeostatic response to the decreased D 2 receptor numbers observed after chronic cocaine administration.
Another possibility is that the increase in presynaptic D 2 receptor coupling would result in reducing dopamine release and thus contribute to the "hypodopaminergic" state which is indicative of escalating dose cocaine administered animals.
As quinerolane has been shown to bind to D 2 receptors as well as D 3 receptors with high affinity (Gackenheimer et al., 1995) , there is a possibility that the increase in quinerolane In addition to the opposite changes in D 2 receptor binding and activity observed in our study, a significant increase in DAT binding was observed in the striatum of mice treated with a chronic "binge" escalating dose cocaine administration paradigm. This is in agreement with studies showing increases in the DAT binding and/or dopamine uptake in brains of human cocaine abusers (Staley et al., 1994; Little et al., 1998b; Little et al., 1999; Mash et al., 2002) , in rodents which self administer cocaine (Wilson et al., 1994a) and in rodents which have been chronically treated with cocaine (Pilotte et al., 1994; Claye et al., 1995; Hitri et al., 1996) . This increase in the numbers of DAT following chronic cocaine administration might reflect a compensatory change to modify synaptic dopamine concentration in the striatum and to maintain dopaminergic neurotransmission at more normal levels. Indeed, as cocaine elevates dopamine by blocking reuptake into the presynaptic terminal, one way to compensate for the effect of cocaine would be to enhance the uptake and transport of dopamine across the dopaminergic presynaptic membrane by increasing DAT density. Such increases in DAT might not only contribute to the dopaminergic deficit believed to occur in the brain of escalating dose cocaine self administration (Ahmed et al., 2003; Ahmed & Koob, 2004) , but might also contribute to cocaine withdrawal symptoms that cocaine abusers experience such as depression and suicidability and thus might sustain the rewarding effect of cocaine bingeing (Little et al., 1999) .
A possible mechanism by which chronic escalating dose cocaine administration might increase DAT density is by the activation of the D 2 receptors observed in our study. While Parson et al., (1993) demonstrated that D2 receptor antagonists prevents the upregulation of dopamine uptake that results from chronic intermittent cocaine administration, Mayfield and Zahniser., (2001) found that activation of D 2 receptors via the G i/o coupling results in an increased number of DAT sites. Interestingly, in contrast to our data, a lack of change in DAT density was observed in C57BL/6J mice treated with a 14 day "binge" steady dose (15 x 3 mg/kg/day) administration protocol (Bailey et al., 2007b) .
In contrast with DAT and D 2 receptor density and activity, there was no change in D 1 receptor density in the brains of escalating dose cocaine treated mice compared to saline controls.
Although there is a large body of literature suggesting an important role for D 1 receptors in the expression of cocaine sensitisation (for review see Pierce (2005), Spanagel (1995) and Unterwald et al., (1994) , the lack of D 1 receptor changes in our study suggests that D 1 receptor numbers might not play a role in our escalating pattern of cocaine administration.
These results are in accordance with a previous study in this lab (Bailey et al., 2007b) and treatment x day interaction (P<0.0001) for both escalating and steady dose paradigms.
There was an increase in basal locomotion in the cocaine treated groups vs saline control on The labelling was carried out on sections from chronically cocaine or saline treated C57BL/6J mice in a completely paired protocol. Specific binding was >80 % in all regions analysed.
Two way ANOVA showed a significant main effect of treatment (P < 0.001) for showed a significant main effect of raclopride (reversal) (P < 0.001) and a significant raclopride x treatment (saline, cocaine) interaction (P<0.05) in the escalating dose group.
There was an overall increase in quinerolane stimulated 
